{"log_id": 8720313170957756586, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 1e-06, "average": 0.998958, "min": 0.996557}, "location": {"width": 203, "top": 249, "height": 26, "left": 209}, "words": "皮肤和皮下组织疾病"}, {"probability": {"variance": 0, "average": 0.999767, "min": 0.999559}, "location": {"width": 47, "top": 281, "height": 25, "left": 209}, "words": "皮疹"}, {"probability": {"variance": 6e-06, "average": 0.998314, "min": 0.99078}, "location": {"width": 249, "top": 335, "height": 27, "left": 208}, "words": "肌肉骨骼和结缔组织疾病"}, {"probability": {"variance": 3e-06, "average": 0.998796, "min": 0.990597}, "location": {"width": 716, "top": 364, "height": 29, "left": 207}, "words": "横纹肌溶解症、骨软化症(表现为骨痛,可能造成骨折)、肌无力、肌病"}, {"probability": {"variance": 2e-06, "average": 0.998652, "min": 0.995906}, "location": {"width": 138, "top": 395, "height": 25, "left": 207}, "words": "肾和泌尿疾病"}, {"probability": {"variance": 2e-06, "average": 0.999038, "min": 0.992835}, "location": {"width": 841, "top": 421, "height": 29, "left": 208}, "words": "肾功能不全、肾衰、急性肾衰、 Fanconi综合征、近端肾小管病变、蛋白尿、肌酐升高"}, {"probability": {"variance": 9e-06, "average": 0.998475, "min": 0.988}, "location": {"width": 657, "top": 452, "height": 28, "left": 209}, "words": "急性肾小管坏死、肾性尿崩症、多尿和间质性肾炎(包括急性病例)"}, {"probability": {"variance": 1e-06, "average": 0.999247, "min": 0.996126}, "location": {"width": 270, "top": 508, "height": 26, "left": 209}, "words": "全身性疾病与用药部位状况"}, {"probability": {"variance": 0, "average": 0.99974, "min": 0.999609}, "location": {"width": 46, "top": 537, "height": 26, "left": 209}, "words": "无力"}, {"probability": {"variance": 2e-06, "average": 0.99916, "min": 0.993133}, "location": {"width": 825, "top": 591, "height": 29, "left": 210}, "words": "以下不良反应(已在上述身体系统标题下列出),可能由近端肾小管病变引起:横纹"}, {"probability": {"variance": 2e-06, "average": 0.999183, "min": 0.99274}, "location": {"width": 581, "top": 622, "height": 28, "left": 208}, "words": "肌溶解症、骨软化症、低钾血症、肌无力、肌病、低磷血症"}, {"probability": {"variance": 0, "average": 0.99991, "min": 0.999828}, "location": {"width": 61, "top": 724, "height": 25, "left": 214}, "words": "禁忌"}, {"probability": {"variance": 2e-06, "average": 0.999143, "min": 0.994111}, "location": {"width": 719, "top": 770, "height": 31, "left": 212}, "words": "富马酸替诺福韦二吡呋酯禁用于先前对本药物中任何一种成份过敏的患者"}, {"probability": {"variance": 0.000624, "average": 0.981992, "min": 0.938984}, "location": {"width": 102, "top": 824, "height": 28, "left": 212}, "words": "[注意事项]"}, {"probability": {"variance": 0.004176, "average": 0.979918, "min": 0.727456}, "location": {"width": 368, "top": 874, "height": 30, "left": 209}, "words": "乳酸性酸中毒/严重肝肿大伴脂肪变性"}, {"probability": {"variance": 3.3e-05, "average": 0.998557, "min": 0.964191}, "location": {"width": 824, "top": 904, "height": 29, "left": 212}, "words": "单独使用核苷类似物治疗或联用其它抗逆转录病毒药物治疗时,曾有发生乳酸性酸中"}, {"probability": {"variance": 4e-06, "average": 0.999217, "min": 0.987187}, "location": {"width": 826, "top": 935, "height": 26, "left": 211}, "words": "毒和严重肝肿大伴脂肪变性的报告,包括出现致死病例。这些病例大多数发生在女性"}, {"probability": {"variance": 1.6e-05, "average": 0.997886, "min": 0.985554}, "location": {"width": 836, "top": 964, "height": 27, "left": 212}, "words": "中。肥胖及对核苷的长期暴露可能是危险因素。在有已知肝病危险因素的患者中给予"}, {"probability": {"variance": 0.000108, "average": 0.996579, "min": 0.938659}, "location": {"width": 803, "top": 992, "height": 29, "left": 210}, "words": "核苷类似物时要特别注意;然而,在没有已知危险因素的患者中也曾经有病例报告"}, {"probability": {"variance": 2.6e-05, "average": 0.997697, "min": 0.974866}, "location": {"width": 827, "top": 1022, "height": 28, "left": 209}, "words": "任何患者的临床或实验室结果如果提示有乳酸性酸中毒或显著的肝毒性(可能包括肝"}, {"probability": {"variance": 7.9e-05, "average": 0.995162, "min": 0.963432}, "location": {"width": 827, "top": 1051, "height": 28, "left": 209}, "words": "肿大和脂肪变性,即便转氨酶没有显著升高),应当暂停富马酸替诺福韦二吡呋酯治"}, {"probability": {"variance": 0, "average": 0.999468, "min": 0.999468}, "location": {"width": 26, "top": 1083, "height": 24, "left": 209}, "words": "疗"}, {"probability": {"variance": 0, "average": 0.999666, "min": 0.998636}, "location": {"width": 204, "top": 1134, "height": 26, "left": 211}, "words": "中断治疗后乙肝恶化"}, {"probability": {"variance": 0.000173, "average": 0.996077, "min": 0.922224}, "location": {"width": 817, "top": 1161, "height": 29, "left": 211}, "words": "对感染HBV但中断富马酸替诺福韦二吡呋酯治疗的患者必须严密监测,包括临床及"}, {"probability": {"variance": 3.5e-05, "average": 0.997884, "min": 0.96409}, "location": {"width": 850, "top": 1190, "height": 29, "left": 212}, "words": "实验室随访在停止治疗后还要持续至少几个月的时间。如果条件适当,可以准许患者"}, {"probability": {"variance": 1e-06, "average": 0.999549, "min": 0.997189}, "location": {"width": 248, "top": 1221, "height": 27, "left": 212}, "words": "重新开始抗乙肝病毒治疗"}, {"probability": {"variance": 2e-06, "average": 0.998979, "min": 0.995097}, "location": {"width": 316, "top": 1273, "height": 28, "left": 212}, "words": "新出现的或更严重的肾功能损害"}, {"probability": {"variance": 6.4e-05, "average": 0.99659, "min": 0.963527}, "location": {"width": 833, "top": 1301, "height": 29, "left": 212}, "words": "替诺福韦主要通过肾脏清除。使用富马酸替诺福韦二吡呋酯时,曾有其引起肾功能损"}, {"probability": {"variance": 4.8e-05, "average": 0.997185, "min": 0.958677}, "location": {"width": 848, "top": 1329, "height": 30, "left": 211}, "words": "害的报告,包括出现急性肾衰和 Fanconi综合征(肾小管损伤伴严重低磷酸血症)的"}, {"probability": {"variance": 0.01181, "average": 0.969805, "min": 0.522679}, "location": {"width": 355, "top": 1361, "height": 26, "left": 212}, "words": "病例(参见“不良反应-上市后经验”)"}], "language": 3}